Assessment of the Safety and Efficacy of a Raft-Forming Alginate Reflux Suppressant (Liquid Gaviscon) for the Treatment of Heartburn during Pregnancy

<table class="table-group" width="800px"><tr class="fig-image" id="a"><td><img alt="481870.fig.001a" src="https://static.hindawi.com/articles/isrn/volume-2012/481870/figures/481870.fig.001a.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(a) </b>By the investigator</td></tr></table></td></tr><tr class="fig-image" id="b"><td><img alt="481870.fig.001b" src="https://static.hindawi.com/articles/isrn/volume-2012/481870/figures/481870.fig.001b.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(b) </b>By the patient</td></tr></table></td></tr></table>

<table>Frequency distribution for the ITT population of impression of treatment of heartburn in pregnancy by Liquid Gaviscon at study assessment visit.</table>

International Scholarly Research Notices

fig1

Figure 1

Figure 1: Assessment of the Safety and Efficacy of a Raft-Forming Alginate Reflux Suppressant (Liquid Gaviscon) for the Treatment of Heartburn during Pregnancy 

Figure 1 | Assessment of the Safety and Efficacy of a Raft-Forming Alginate Reflux Suppressant (Liquid Gaviscon) for the Treatment of Heartburn during Pregnancy 